Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21654996 | 0.86 | ALDH1A1 (0.37) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL20055670 | 0.82 | ALDH1A1 (0.37) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL20711850 | 0.81 | TDP1 (0.33) | TDP1 | |
| SCHEMBL17191626 | 0.80 | ALDH1A1 (0.31) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL14885134 | 0.79 | ALDH1A1 (0.33) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL21158918 | 0.79 | ALDH1A1 (0.33) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL20922403 | 0.77 | ALDH1A1 (0.32) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL23223575 | 0.76 | ADRB2 (0.34) | CYP3A4TSHRTDP1 | |
| SCHEMBL23385283 | 0.76 | DNM1 (0.35) | ALDH1A1CYP3A4TSHRDNM1OPRM1 | |
| SCHEMBL21701472 | 0.76 | METAP1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130079319-A1 | CEPHEM COMPOUND HAVING PSEUDO-CATECHOL GROUP | SHIONOGI & CO., LTD. (JP) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079319-A1 | CEPHEM COMPOUND HAVING PSEUDO-CATECHOL GROUP | CENPE, CCNE2, CEP170 | ALDH1A1 2841/4885CYP3A4 928/4885TSHR 4026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.